複雑性尿路感染症に対するT-2588の臨床的検討
スポンサーリンク
概要
- 論文の詳細を見る
複雑性尿路感染症の21例に対して,T-2588を投与した.1)総合臨床効果は著効7例(33.3%),有効8例(38.1%),無効6例(28.6%)と総合有効率は71.4%でった.2)疾患病態群別における有効率は,第1群100%,第3群100%,第4群83.3%,第5群16.7%,第6群100%であった.3)分離された35株中27株(77.1%)が消失した.グラム陽性菌は8株中5株(62.5%)グラム陰性菌は27株中22株(81.5%)であった.4) MIC値が6.25 μg/ml以下の細菌はすべて陰性化し,MIC値と細菌の消失率はよく相関していた.5)自・他覚的副作用及び臨床検査値異常はすべて認められなかったThe clinical effectiveness and safety of T-2588 were evaluated in 21 patients with complicated urinary tract infections. Six hundred mg of T-2588 per day was administered orally in three divided doses for 14 days. The results were excellent in 7 cases (33.3%), moderate in 8 cases (38.1%) and poor in 6 cases (28.6%), and the effectiveness rate was 71.4%. The effectiveness rates of the single infection group and mixed infection group were 91.7% and 44.4%, respectively. The overall bacteriological eradication rate obtained was 77.1%, and those of gram-positive cocci and gram-negative rods were 62.5% and 81.5%, respectively. None of the 21 cases, had any significant side effects and abnormal laboratory findings. From the above results, T-2588 is considered to be a useful antibiotic in the treatment of complicated urinary tract infections.
論文 | ランダム
- Active Cutaneous Anaphylaxisの検討
- ひずみ硬化型繊維補強セメント複合材料の付着性状 Shih-Ho Chao,Antoine E.Naaman and Gustavo J.Parra-Montesinos:Bond Behavior of Reinforcing Bars in Tensile Strain-Hardening Fiber-Reinforced Cement Composites [ACI Structural Journal, Vol.106, No.6, November-December 2009,pp.897-906
- CFDによる火災旋風と火の粉の飛散解析
- Mr. Democracy and Mr. Constitutionalism (国際セミナー 清華大学法学院とのセミナー「中国における法治社会構築の現状」)
- 国際セミナー 清華大学法学院とのセミナー「中国における法治社会構築の現状」